anti-HER2 TCR, pCDTCR1(TCR-L049Z)
The vector of anti-HER2 T cell receptor (TCR) is constructed for the engineering of T cell to target Human HER2. The T cells are genetically modified through transduction with a retroviral vector expressing HER2-specific T cell receptor. And the vector product was designed for the treatment of breast, ovary, stomach, kidney, colon, and lung cancer.
Breast, ovary, stomach, kidney, colon, and lung cancers
erb-b2 receptor tyrosine kinase 2
ERBB2; erb-b2 receptor tyrosine kinase 2; NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu; receptor tyrosine-protein kinase erbB-2; herstatin; p185erbB2; proto-oncogene Neu; c-erb B2/neu protein; proto-oncogene c-ErbB-2; metastatic lymph node gene 19 protein; human epidermal growth factor receptor 2; neuro/glioblastoma derived oncogene homolog; tyrosine kinase-type cell surface receptor HER2; neuroblastoma/glioblastoma derived oncogene homolog; v-erb-b2 avian erythroblastic leukemia viral oncoprotein 2; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog; CD28; Chimeric antigen receptor; T cell; Retrovirus; CARs; Lentivirus; chimeric T cell receptors; chimeric immunoreceptors; chimeric antigen receptors; scFv; OTI5C4
This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
||Lenti-ErbB2 CAR (scFv-CD28-CD3ζ, C6.5) Viral Particle
||Lenti-ErbB2 CAR (scFv-CD28-CD3ζ, C6-B1D2) Viral Particle
||Human anti-Her2 T cell receptor (G8), pCDTCR1
||Anti-HER2 VHH h(CD28-41BB-CD3ζ) CAR, [T]
||Lenti-ErbB2 CAR (scFv-FcεRIγ, OTI5C4) Viral Particle
||Anti-ErbB2 scFv h(CD4-FcεRIγ) CART, pCDCAR1
||Lenti-ErbB2 CAR (scFv-CD28-FcεRIγ, OTI5C4) Viral Particle
||Anti-HER2 VHH h(b2c-CD3ζ) CAR, [T]
||Lenti-ErbB2 CAR (scFv-41BB-CD3ζ, OTI5C4) Viral Particle
||Lenti-ErbB2 CAR (scFv-CD28-FcγR, 4D5 ) Viral Particle